Addex convenes extraordinary general meeting

Ad hoc announcement pursuant to art. 53 lr geneva, switzerland, november 28, 2023 - addex therapeutics (six: adxn and nasdaq: adxn), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that an extraordinary general meeting is convened and will take place on tuesday december 19, 2023, at 11:00 am cet at the campus biotech, chemin des mines 9, 1202 geneva (doors open at 10:30 am).
ADXN Ratings Summary
ADXN Quant Ranking